Roby Joyce - 12 Jun 2024 Form 4 Insider Report for bioAffinity Technologies, Inc. (BIAF)

Role
Director
Signature
/s/ Maria Zannes, Attorney-in-fact for Roby Joyce
Issuer symbol
BIAF
Transactions as of
12 Jun 2024
Transactions value $
$0
Form type
4
Filing time
14 Jun 2024, 20:45:57 UTC
Previous filing
24 Jan 2024
Next filing
02 Jul 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIAF Common Stock Award $0 +8,296 +33.81% $0 32,831 12 Jun 2024 Direct F1
holding BIAF Common Stock 583,130 12 Jun 2024 The Joyce Living Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted shares of common stock, par value $0.007 per share, that vest immediately.
F2 Dr. Joyce is the co-Trustee of The Joyce Living Trust (the "Trust"), together with his wife, Joyce M. Joyce, each of whom may act unilaterally with regard to voting and disposition power with respect to the shares owned by the Trust. Dr. Joyce and Mrs. Joyce are the beneficiaries of the Trust.